U.S. flag

An official website of the United States government

NM_153240.5(NPHP3):c.2694-2_2694-1del AND multiple conditions

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Mar 19, 2025
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002500658.7

Allele description [Variation Report for NM_153240.5(NPHP3):c.2694-2_2694-1del]

NM_153240.5(NPHP3):c.2694-2_2694-1del

Genes:
NPHP3-ACAD11:NPHP3-ACAD11 readthrough (NMD candidate) [Gene - HGNC]
NPHP3:nephrocystin 3 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
3q22.1
Genomic location:
Preferred name:
NM_153240.5(NPHP3):c.2694-2_2694-1del
Other names:
splice site
HGVS:
  • NC_000003.12:g.132689264_132689265del
  • NG_008130.2:g.38168_38169del
  • NM_153240.5:c.2694-2_2694-1delMANE SELECT
  • NC_000003.11:g.132408108_132408109del
  • NG_008130.1:g.38168_38169del
  • NM_153240.4:c.2694-2_2694-1del
  • NM_153240.4:c.2694-2_2694-1delAG
  • NM_153240.5:c.2694-2_2694-1delAGMANE SELECT
  • c.2694-2_2694-1delAG
Links:
OMIM: 608002.0004; dbSNP: rs751527253
Molecular consequence:
  • NM_153240.5:c.2694-2_2694-1del - splice acceptor variant - [Sequence Ontology: SO:0001574]
Observations:
1

Condition(s)

Name:
Renal-hepatic-pancreatic dysplasia 1 (RHPD1)
Identifiers:
MONDO: MONDO:0008833; MedGen: C3715199; OMIM: 208540
Name:
Nephronophthisis 3 (NPHP3)
Synonyms:
Adolescent nephronophthisis
Identifiers:
MONDO: MONDO:0011456; MedGen: C1858392; Orphanet: 655; OMIM: 604387
Name:
NPHP3-related Meckel-like syndrome
Synonyms:
GOLDSTON SYNDROME; Meckel syndrome type 7
Identifiers:
MONDO: MONDO:0009966; MedGen: C2673885; Orphanet: 3032; OMIM: 267010

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002810601Fulgent Genetics, Fulgent Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 8, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV005871551Juno Genomics, Hangzhou Juno Genomics, Inc
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicgermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV007580611First Genomix Gene Laboratory, Genetic Diagnostics Department
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 19, 2025)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineno1not providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Fulgent Genetics, Fulgent Genetics, SCV002810601.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Juno Genomics, Hangzhou Juno Genomics, Inc, SCV005871551.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Absent from controls (or at extremely low frequency if recessive) in Genome Aggregation Database, Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium.;For recessive disorders, detected in trans with a pathogenic variant.;Patient's phenotype or family history is highly specific for a disease with a single genetic etiology.;Co-segregation with disease in multiple affected family members in a gene definitively known to cause the disease.;Null variant in a gene where loss of function (LOF) is a known mechanism of disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From First Genomix Gene Laboratory, Genetic Diagnostics Department, SCV007580611.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

As part of Carrier Screening testing performed at First Genomix, this variant was identified in a heterozygous state in a patient who is not affected with this condition.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot provided1not providednot providednot provided

Last Updated: Jul 14, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search